Company · CIK 1880995
Alopexx, Inc.
| CIK | 1880995 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-263328 | 2022-03-07 | 2026-09-17 | 20 |
Filings
21| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-17 | S-1/AAmendment | 333-263328 | 0001213900-26-101026 |
| 2026-08-17 | S-1/AAmendment | 333-263328 | 0001213900-26-090319 |
| 2026-06-26 | S-1/AAmendment | 333-263328 | 0001213900-26-072480 |
| 2025-02-25 | S-1/AAmendment | 333-263328 | 0001213900-25-016709 |
| 2025-01-08 | S-1/AAmendment | 333-263328 | 0001839882-25-001330 |
| 2024-09-09 | S-1/AAmendment | 333-263328 | 0001999371-24-011702 |
| 2024-03-14 | S-1/AAmendment | 333-263328 | 0001999371-24-003528 |
| 2023-12-27 | S-1/AAmendment | 333-263328 | 0001999371-23-001220 |
| 2023-02-01 | S-1/AAmendment | 333-263328 | 0001387131-23-001140 |
| 2022-12-15 | S-1/AAmendment | 333-263328 | 0001387131-22-012441 |
| 2022-11-18 | S-1/AAmendment | 333-263328 | 0001387131-22-011531 |
| 2022-10-07 | S-1/AAmendment | 333-263328 | 0001387131-22-010319 |
| 2022-09-07 | S-1/AAmendment | 333-263328 | 0001387131-22-009513 |
| 2022-08-24 | S-1/AAmendment | 333-263328 | 0001387131-22-009029 |
| 2022-07-12 | S-1/AAmendment | 333-263328 | 0001387131-22-007654 |
| 2022-05-31 | S-1/AAmendment | 333-263328 | 0001387131-22-006625 |
| 2022-05-02 | S-1/AAmendment | 333-263328 | 0001387131-22-005622 |
| 2022-04-20 | S-1/AAmendment | 333-263328 | 0001387131-22-005035 |
| 2022-04-07 | S-1/AAmendment | 333-263328 | 0001387131-22-004650 |
| 2022-03-07 | S-1Registration filed | 333-263328 | 0001387131-22-003216 |
| 2022-01-07 | DRSDraft made public | 377-05910 | 0001387131-22-000166 |